Mouritzen, Mette T ;
Carus, Andreas ;
Ladekarl, Morten...
Mouritzen , M T , Carus , A , Ladekarl , M , Meldgaard , P , Nielsen , A W M , Livbjerg , A , Larsen , J W , Skuladottir , H , Kristiansen , C , Wedervang , K , Schytte , T , Hansen , K H , Østby , A C , Frank , M S , Lauritsen , J , Sørensen , J B , Langer , S W , Persson , G F , Andersen , J L , Frary , J M C , Drivsholm , L B , Vesteghem , C , Christensen , H S , Bjørnhart , B & Pøhl , M 2021 , ' Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy ' , Cancers , vol. 13 , no. 19 , 4846 . https://doi.org/10.3390/cancers13194846.
,
2021
